Human genetic factors predispose to tuberculosis (TB).
We studied 7.6 million genetic variants in 5,530 people with pulmonary TB and in 5,607 healthy controls. In the combined analysis of these subjects and the follow-up cohort (15,087 TB patients and controls altogether), we found an association between TB and variants located in introns of the ASAP1 gene on chromosome 8q24 (P = 2.6 × 10 −11 for rs4733781; P = 1.0 × 10 −10 for rs10956514). Dendritic cells (DCs) showed high ASAP1 expression that was reduced after Mycobacterium tuberculosis infection, and rs10956514 was associated with the level of reduction of ASAP1 expression. The ASAP1 protein is involved in actin and membrane remodeling and has been associated with podosomes. The ASAP1-depleted DCs showed impaired matrix degradation and migration. Therefore, genetically determined excessive reduction of ASAP1 expression in M. tuberculosis-infected DCs may lead to their impaired migration, suggesting a potential mechanism of predisposition to TB.
Tuberculosis (TB) is a major public-health problem in the developing world and an increasing threat in developed countries 1 . Although 2 billion people are estimated to be infected with M. tuberculosis, only ~10% of infected individuals eventually develop active TB 1 . In most carriers, the infection remains latent and clinical disease never occurs. Case observations, twin studies and mouse models indicate that host genetic factors are important in determining susceptibility to M. tuberculosis 2, 3 . Recent genome-wide association studies (GWAS) reported two loci on chromosomes 11p13 and 18q11 that contain single-nucleotide polymorphisms (SNPs) associated with TB 4, 5 .
However, the pathophysiological mechanisms underpinning these genetic associations remain unknown.
To identify genes associated with susceptibility to TB, we initially studied 5,914 people who were HIV negative and had active pulmonary TB confirmed by culture of M. tuberculosis from sputum, as well as 6,022 healthy adult controls from Russia (Online Methods). We genotyped their DNA using Affymetrix Genome-Wide Human SNP Array 6.0. After rigorous quality control (Online Methods and Supplementary Figs. 1 and 2) , the remaining data set comprised 5,530 TB patients and 5,607 controls with high-quality genotypes at 707,452 SNPs (set 1). We then imputed genotypes at 7,614,862 SNPs into the set 1 subjects using data from the 1000 Genomes Project. We tested these SNPs for association with TB using logistic regression corrected for four principal components and did not observe significant inflation of test statistics (λ GC = 1.10), indicating that our cases and controls were well matched (Supplementary Fig. 3 ).
We first examined our association results in the context of previously published TB GWAS in two African populations 4, 5 . We did not detect any association at the previously reported 18q11 locus. However, we did see association at the 11p13 locus (rs2057178, P = 0.00068, logistic regression, Supplementary Table 1), as we reported previously for the overlapping Russian data set 5 . This is consistent with a recently published TB GWAS in a South African population 6 and suggests that the 11p13 locus is associated with TB risk in various populations, whereas the association of TB with the 18q11 locus may be population specific. We next studied candidate genes previously reported to be associated with TB and found weak signals in several, including the HLA-DQA1 region (Supplementary Table 2 ). We then looked for overlap with published genetic associations in human Susceptibility to tuberculosis is associated with variants in the ASAP1 gene encoding a regulator of dendritic cell migration l e t t e r s leprosy 7, 8 , another mycobacterial infectious disease, and in inflammatory bowel disease (IBD) because the set of the IBD-associated genes is enriched with genes involved in defense against mycobacteria 9 . We found that, except for the MHC region, none of those loci was significantly associated with TB after Bonferroni correction (Supplementary Tables 3 and 4) .
Our only genome-wide significant TB-associated locus was on chromosome 8q24 (11 SNPs in introns of the ASAP1 gene, P < 5 × 10 −8 ) (Fig. 1) ; the strongest association was at rs2033059 (P = 1.1 × 10 −8 , logistic regression). To rule out technical artifacts and to attempt to replicate our discovery, we designed individual TaqMan genotyping assays for seven of the most significantly associated ASAP1 SNPs. We genotyped these SNPs in set 1 and, additionally, in 1,085 people with pulmonary TB and 2,865 controls from Russia (set 2). In the combined analysis of 15,087 subjects in sets 1 and 2, all seven SNPs showed convincing evidence of association with TB (Table 1) ; the most significant association was at rs4733781 (P = 2.6 × 10 −11 , logistic regression). To try to identify which of these seven SNPs is likely to be the functional polymorphism affecting risk of pulmonary TB, we employed a Bayesian fine-mapping approach (Online Methods). Three SNPs had <5% posterior probability of being causal, leaving four likely candidates ( Table 1) , with rs4733781 having the highest posterior probability (43.6%). This narrowing to four candidates is likely to represent the limit of genetic resolution in our Russian data set.
We then analyzed the seven ASAP1 SNPs in previously published Ghanaian (971 TB cases and 988 controls) and Gambian (1,306 TB cases and 1,372 controls) GWAS data sets 4,5 ( Table 2 ). These SNPs were less frequent in the African populations than in the Russian one, resulting in lower statistical power to detect association, but this analysis provided further support for TB association of the ASAP1 SNPs; for rs4733781, for example, effects in the Ghanaian and Gambian data sets were similar to those in the Russian data set (odds ratio (OR) = 0.89, 0.89 and 0.84, respectively; P Ghana+Gambia = 0.052; overall P Russia+Ghana+Gambia = 3.6 × 10 −12 ).
ASAP1 (also known as AMAP1 or DDEF1) encodes an Arf GTPaseactivating protein (Arf GAP), a multifunctional scaffold protein that induces hydrolysis of GTP bound to the ADP ribosylation factor family GTP-binding (Arf) proteins 10 npg l e t t e r s proteins regulate coordinated actin and membrane remodeling 11 . In NIH 3T3 mouse fibroblasts, localization of ASAP1 protein is associated with focal adhesions, circular dorsal ruffles, podosomes and invadopodia-large macromolecular complexes that connect intracellular actin cytoskeleton to the extracellular matrix and are important for cell adhesion and migration, as well as invasion of cancer cells 11 . A cell's transition from a quiescent phenotype to a migratory one is characterized by the dissolution of focal adhesions and the formation of podosomes or invadopodia at sites of contact with the extracellular matrix 12 . In vitro knockdown and reduction of ASAP1 expression in transformed fibroblast and prostate cancer cell lines prevents formation of invadopodia and suppresses cell migration and invasiveness 13, 14 . Overexpression of ASAP1 has been associated with metastasis in several cancers [14] [15] [16] [17] . Whereas invadopodia are found in transformed cells, podosomes are similar structures but are present in several types of normal cells, including macrophages and DCs 12 . These immune cells have crucial roles in TB pathogenesis. The infection is initiated when inhaled M. tuberculosis bacilli are phagocytosed by alveolar macrophages, which provide a cellular niche for the expansion of mycobacteria. The onset of adaptive immune response leads to killing of mycobacteria and sterilization of regional lesions 18 . DCs are crucial for the initiation of the adaptive immunity: infected DCs migrate to the lung-draining lymph nodes and activate T cells 19 . M. tuberculosis is known to inhibit migration as well as other functions of DCs, and adaptive immunity is delayed in TB compared with other microbial infections [20] [21] [22] . The role of ASAP1 in macrophages, DCs and other immune cells has not been studied previously. To investigate it, we initially characterized ASAP1 mRNA expression by quantitative reverse transcription PCR (qRT-PCR) in primary leukocytes from healthy donors and found that monocytes, B lymphocytes, CD4 + and CD8 + T lymphocytes and neutrophils express low levels of ASAP1. However, when monocytes were differentiated into macrophages or DCs, the expression of ASAP1 increased (Fig. 2a) . We then infected DCs with Mycobacterium bovis BCG and found that it led to the reduction of ASAP1 expression (Fig. 2a) . We also analyzed ASAP1 expression in DCs from 65 subjects who were previously studied using microarrays 23 . Similarly to our results, in this data set ASAP1 expression levels were significantly lower in M. tuberculosis-infected DCs than in noninfected DCs (log 2 fold change = −0.49, P corrected = 2.9 × 10 −18 (ref. 23) ). To study whether any of the TB-associated SNPs in the ASAP1 gene affect its expression, we first analyzed rs10956514 and rs4733781, which were genotyped in this data set. The SNP rs10956514 showed evidence of association with ASAP1 expression in noninfected samples (P = 4.6 × 10 −3 ) and with the relative level of reduction in ASAP1 expression after M. tuberculosis infection (P = 4.6 × 10 −3 ). Homozygotes of allele A, which was associated with higher TB risk in our GWAS, showed stronger reduction of ASAP1 expression after infection than homozygotes of allele G, which was associated with lower TB risk (Fig. 2b) . We imputed genotypes of other TB-associated ASAP1 SNPs and found that they had weaker association with the degree of reduction of ASAP1 expression after M. tuberculosis infection than did rs10956514 (Supplementary Table 5 ). The lack of association between ASAP1 expression and rs4733781 reflects different linkage disequilibrium patterns in this region (for example, r 2 between rs4733781 and rs10956514 was 0.8 in the Russian data set, but only 0.62 in 65 non-Russian Caucasians) 23 . These results indicate that larger studies in different populations will be needed to pinpoint the causative variant affecting ASAP1 expression and the risk of pulmonary TB. Nevertheless, our results npg l e t t e r s suggest that either rs10956514 or a polymorphism in strong linkage disequilibrium with it may be responsible for the control of ASAP1 expression in DCs. As rs10956514 is also one of the candidates associated with the risk of active pulmonary TB (Table 1) , genetically regulated levels of ASAP1 expression in DCs are likely to be important in TB pathogenesis.
To investigate the role of the ASAP1 protein in DCs, we first studied its cellular localization. Confocal microscopy showed that ASAP1 was localized in the cytoplasm and was partly associated with podosomes (Fig. 3a) . Therefore, we hypothesized that reduced ASAP1 expression may affect matrix degradation by DCs and their migration. To test this, we isolated primary monocytes from healthy volunteers, derived DCs in vitro and transfected them with short interfering RNA (siRNA) to reduce ASAP1 expression. We found that ASAP1-depleted DCs showed impaired ability to degrade a gelatin matrix (Fig. 3b) and migrated significantly more slowly than control cells (Fig. 3c) .
Taken together, our results suggest that impaired migration of M. tuberculosis-infected DCs caused by the genetically determined excessive reduction of ASAP1 expression may contribute to TB pathogenesis. This may be one of the mechanisms that lead to the slow migration of DCs to lymph nodes and delay the adaptive immune response during early stages of TB infection. Furthermore, given that latent TB is a state of dynamic equilibrium, it is likely that trafficking of immune cells in granulomas has to be constantly maintained 19 . Therefore, impaired migration of DCs and/or macrophages owing to reduced ASAP1 expression may also be important at late stages of infection leading to reactivation of latent TB.
To date, GWAS of susceptibility to TB and other infectious diseases have identified fewer associated loci than have studies of many other complex diseases. This indicates that the effects of common polymorphisms predisposing to infection are usually small, and current GWAS may be statistically underpowered. In TB this can be explained by the strong selective pressure exerted by M. tuberculosis, an ancient and widespread pathogen. Nevertheless, our results demonstrate that when associated variants are found, they can highlight new molecular mechanisms implicated in infection and host responses. Future studies will further clarify how the ASAP1-mediated pathways are involved in mycobacterial infection and in predisposition to TB.
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oNLINe MeTHoDS
Ethics. Blood samples from all participants were collected and studied with written informed consent according to the Declaration of Helsinki and with approvals from the local ethics committees in Russia (St. Petersburg and Samara) and the UK (Human Biological Resource Ethics Committee of the University of Cambridge and the National Research Ethics Service, Cambridgeshire 1 REC, 10/H0304/71).
TB patients and controls. Pulmonary TB patients attending civilian TB dispensaries and TB clinics along with healthy subjects attending the blood transfusion service were recruited in two Russian cities, St. Petersburg and Samara, as described previously 24 . TB patients were diagnosed with information about TB contact, medical history and clinical symptoms (cough, hemoptysis, chest pain, fever, weight loss), presence of acid-fast bacilli in sputum smear and symptoms characteristic of pulmonary TB on chest X-rays. For all patients included in this study, diagnosis was confirmed by culture of M. tuberculosis from sputum. We excluded patients with extrapulmonary TB and subjects who were HIV positive. Controls were healthy adult bloodbank donors with no history of TB. M. tuberculosis infection status of these controls was unknown. We studied genotypes of 15,087 subjects, including 6,615 TB patients (4,074 from St. Petersburg and 2,541 from Samara) and 8,472 controls (5,555 from St. Petersburg and 2,917 from Samara). Average age was 45 years for patients and 31 years for controls. 73% of patients and 71% of controls were male. This sample size provides >80% statistical power to detect association with P = 5 × 10 −8 for polymorphisms with minor allele frequency (MAF) > 20% and odds ratio (OR) > 1.2.
Genotyping, quality control and association analyses. We extracted genomic DNA from whole blood of the participating subjects using a standard chloroform-proteinase K protocol. We checked DNA quality using 1% agarose gel electrophoresis, determined DNA concentration using PicoGreen assay and then normalized concentration for genotyping. In GWAS, genotyping was done using the Affymetrix Genome-Wide Human SNP Array 6.0. Genotypes were called in 5,914 TB cases and 6,022 controls using Birdseed 25 . Individuals were excluded if they had more than 2% missing genotype data or showed excess of heterozygous genotypes (± 3.5 s.d., Supplementary Fig. 1 ). For each pair of individuals, we calculated identity by state (IBS) and excluded samples with IBS > 80% as probable duplicates or close relatives. Finally, IBS was also calculated between each sample from this study and 1,397 samples from the International HapMap project. The IBS relationships were converted to distance and projected onto two axes of multidimensional scaling. We removed non-European-ancestry outliers on the basis of these projections (Supplementary Fig. 2a) . After removing these individuals, we excluded SNPs with a call rate of less than 98%, Hardy-Weinberg P < 10 −6 (in controls), missing rate per SNP difference in cases and controls >0.02 or a minor allele frequency less than 1%. In total, 799 individuals and 175,385 SNPs were excluded, leaving for analysis 707,452 SNPs in 5,530 cases and 5,607 controls (set 1). Principal component analysis was performed across autosomal SNPs within set 1 (Supplementary Fig. 2b,c) . We computed the first ten principal components and decided to include the top four in our downstream analysis to account for population structure remaining in our data set.
We imputed SNPs from the 1000 Genomes Phase I (interim) release into our set 1 samples using IMPUTE2 (refs. 26,27) . Imputed SNPs were excluded if the imputation quality score r 2 was <0.5 and minor allele frequency was <1%. After filtering, 7,614,862 SNPs were left for further association analyses.
TB association was tested with logistic regression implemented in SNPTEST 28 on genotype likelihoods from imputation, with four PCs as covariates. The genomic control inflation factor λ GC for SNPs before and after imputation was 1.10 ( Supplementary Fig. 3 ), indicating that we successfully controlled for any residual population structure between cases and controls.
We genotyped seven ASAP1 SNPs using custom TaqMan assays (Supplementary Table 6 ) and 7900HT system (Applied Biosystems). We visually checked all genotype clusters, assigned calls and extracted genotypes using SDS 2.3 software. TB association was tested in STATA11 using logistic regression, with the city of the sample origin (St. Petersburg or Samara) as a covariate.
To conduct Bayesian fine-mapping we calculated marginal likelihoods for each SNP and Bayes factor using a normal prior with mean = 0 and variance = 0.2. Posterior probabilities were assigned using the relative contribution of each SNP's Bayes factor to the sum of Bayes factors across all seven SNPs 29 .
We analyzed the seven ASAP1 SNPs in the Ghanaian and Gambian TB GWAS data sets that were published previously 4, 5 . The Gambian data set is available in the European Genome-phenome Archive (EGAS00000000027). Both Ghanaian and Gambian data sets were quality controlled by filtering individuals with discordant sex information, elevated missing data rates (>2%), outlying heterozygosity rate (± 3.5 s.d.), duplicated or related individuals with IBS >80% and divergent ancestry on the basis of principal component projections using the HapMap data set. In total, 101 (13 cases and 88 controls) and 316 (192 cases and 124 controls) individuals were excluded from Ghanaian and Gambian data sets, respectively. After individual quality control, we imputed the seven ASAP1 SNPs from the 1000 Genomes Phase I (interim) release into Ghanaian and Gambian samples using IMPUTE2 (refs. 26,27) and tested TB association with logistic regression implemented in SNPTEST.
donkey anti-mouse IgG (Molecular Probes). For western blots, the following antibodies were used: anti-ASAP1 antibody (ab11011, Abcam; diluted 1:1,000) and anti-Actin antibody (A5441, Sigma; diluted 1:50,000).
qRT-PCR. Two-step qRT-PCR was used for analysis of the ASAP1 mRNA expression in neutrophils, monocytes, CD4 + T cells, CD8 + T cells, B cells, monocyte-derived macrophages and monocyte-derived DCs. Total RNA was isolated from cells using Isolate RNA Mini Kit as per the manufacturer's instructions (Bioline UK, BIO-52044). Then the first-strand cDNA was generated from 200 ng of total RNA using Thermo Scientific Maxima Reverse Transcriptase (Thermo Scientific, UK, EP0741) and diluted 1:5. Then 2 µl was taken for qPCR using KAPA SYBR FAST Universal qPCR kit (Kapa Biosystems, UK, KK4602), ASAP1 primers and primers for the gene encoding β2 microglobulin (Supplementary Table 7) . qPCR reactions were done in triplicate. The data were analyzed using ∆C t values, providing ASAP1 mRNA expression levels relative to that of β2 microglobulin mRNA. siRNA transfection. DCs were transfected at day 1 and day 4 using Hiperfect (Qiagen) with either a pool of three ASAP1-specific siRNAs (Supplementary Table 7 ) or a control, scrambled siRNA (1027281, Qiagen). Western blotting with the anti-ASAP1 antibody (ab11011, Abcam; diluted 1:1,000) was done in each case to assess knockdown efficiency. Results were analyzed only if expression of the ASAP1 protein in cells treated with the ASAP1 siRNA was reduced to below 60% of that in cells treated with the control siRNA.
DC matrix degradation assay. Coverslips were coated with 0.2 mg/ml FITCcoupled gelatin (G13187, Molecular Probes) and subsequently blocked using complete medium. The siRNA-treated cells were seeded on the cover slips and incubated at 37 °C for 4 h and fixed with 4% PFA. The cells were labeled with Alexa Fluor 568-coupled phalloidin (A12380, Molecular Probes) and mounted in anti-fade with DAPI (P36931, Molecular Probes). Cells were imaged on a Leica SP5 confocal microscope. The images were processed using ImageJ (Wayne Rasband, NIH). Matrix degradation was quantified by measuring the area where the FITC-labeled gelatin was below the threshold and counting the number of cells using ImageJ, as described before 31 .
DC migration assay. The siRNA-treated cells were seeded on coverslips coated with 0.025 mg/ml fibronectin (F1141, Sigma) and incubated at 37 °C for 4 h in their usual medium without GM-CSF or IL-4. Coverslips were then inverted onto Dunn chambers containing GM-CSF (100 U/ml). The cells were imaged every 2-4 min for a minimum of 2 h in the 37 °C chamber of Leica SPE. Images were processed and analyzed using the manual track plugin of ImageJ, and velocity was calculated.
